Patent Analytics
patent-analytics.thechemsolver.comThe atoms are public, the answer isn't.
← Patent Expiry Watch
October 25, 2026 · Patent expires May 10, 2044

SUN PHARMACEUTICAL INDUSTRIES INC: DEURUXOLITINIB PHOSPHATE (May 10, 2044): The Generic Opportunity Window

SUN PHARMACEUTICAL INDUSTRIES INC: DEURUXOLITINIB PHOSPHATE (May 10, 2044): The Generic Opportunity Window

SUN PHARMACEUTICAL INDUSTRIES INC's core patent for DEURUXOLITINIB PHOSPHATE (12247034) expires on May 10, 2044. ZERO generic (ANDA) approvals exist for this active ingredient as of October 25, 2026. No real litigation signal found.

What we do

We track expirations like this continuously

This is one drug, picked for today's post. A Portfolio Retainer watches an entire portfolio or compound class on an ongoing basis and flags new matching filings as they publish.